{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:33:06Z","timestamp":1791289986766,"version":"4.3.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T00:00:00Z","timestamp":1482969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hartstichting (NL)","award":["2003B261"],"award-info":[{"award-number":["2003B261"]}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["NSN PV01"],"award-info":[{"award-number":["NSN PV01"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["IK08.03"],"award-info":[{"award-number":["IK08.03"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Genzyme (US)"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0168117","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T20:43:55Z","timestamp":1483994635000},"page":"e0168117","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Uremic Solutes in Chronic Kidney Disease and Their Role in Progression"],"prefix":"10.1371","volume":"11","author":[{"given":"Jan A. J. G.","family":"van den Brand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henricus A. M.","family":"Mutsaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan D.","family":"van Zuilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Blankestijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra H.","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans G. M.","family":"Russel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinde","family":"Masereeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack F. M.","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,29]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1681\/ASN.V1081815","article-title":"Pathophysiologic effects of uremic retention solutes","volume":"10","author":"R Vanholder","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"F Duranton","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"R Vanholder","year":"2003","journal-title":"Kidney Int"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"e71199","DOI":"10.1371\/journal.pone.0071199","article-title":"Optimized metabolomic approach to identify uremic solutes in plasma of stage 3\u20134 chronic kidney disease patients","volume":"8","author":"HA Mutsaers","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"e18438","DOI":"10.1371\/journal.pone.0018438","article-title":"Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations","volume":"6","author":"HA Mutsaers","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/labinvest.2011.194","article-title":"Indoxyl sulfate-induced epithelial-to-mesenchymal transition and apoptosis of renal tubular cells as novel mechanisms of progression of renal disease","volume":"92","author":"SH Kim","year":"2012","journal-title":"Lab Invest"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"e34026","DOI":"10.1371\/journal.pone.0034026","article-title":"Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition","volume":"7","author":"CY Sun","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000330852","article-title":"Indoxyl sulfate induces epithelial-to-mesenchymal transition in rat kidneys and human proximal tubular cells","volume":"34","author":"D Bolati","year":"2011","journal-title":"Am J Nephrol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1021\/pr200093w","article-title":"Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1)","volume":"10","author":"WR Wikoff","year":"2011","journal-title":"J Proteome Res"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"KM Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pharmthera.2010.02.007","article-title":"Therapeutic implications of renal anionic drug transporters","volume":"126","author":"R Masereeuw","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"F1599","DOI":"10.1152\/ajprenal.00473.2006","article-title":"Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats","volume":"292","author":"R Schneider","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"e36637","DOI":"10.1371\/journal.pone.0036637","article-title":"Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition","volume":"7","author":"IS Song","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.phrs.2011.11.003","article-title":"Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3","volume":"65","author":"Y Uwai","year":"2012","journal-title":"Pharmacol Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"26715","DOI":"10.1038\/srep26715","article-title":"Bioengineered kidney tubules efficiently excrete uremic toxins","volume":"6","author":"J Jansen","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.tiv.2015.07.020","article-title":"Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology","volume":"29","author":"HA Mutsaers","year":"2015","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1159\/000313491","article-title":"Spherical carbon adsorbent (AST-120) protects deterioration of renal function in chronic kidney disease rats through inhibition of reactive oxygen species production from mitochondria and reduction of serum lipid peroxidation","volume":"115","author":"S Owada","year":"2010","journal-title":"Nephron Exp Nephrol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbadis.2012.09.006","article-title":"Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration","volume":"1832","author":"HA Mutsaers","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11255-012-0258-1","article-title":"An update on uremic toxins","volume":"45","author":"N Neirynck","year":"2013","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.ajkd.2009.05.011","article-title":"Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial","volume":"54","author":"T Akizawa","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/ki.2012.137","article-title":"Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease","volume":"82","author":"AD van Zuilen","year":"2012","journal-title":"Kidney Int"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"e0140820","DOI":"10.1371\/journal.pone.0140820","article-title":"The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites","volume":"10","author":"R Poesen","year":"2015","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"D801","DOI":"10.1093\/nar\/gks1065","article-title":"HMDB 3.0\u2014The Human Metabolome Database in 2013","volume":"41","author":"DS Wishart","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"8476","key":"ref24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"JM Bland","year":"1986","journal-title":"Lancet"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"FC Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2215\/CJN.07971109","article-title":"p-Cresol and cardiovascular risk in mild-to-moderate kidney disease","volume":"5","author":"BK Meijers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2014.02.010","article-title":"The Kidney and Uremic Toxin Removal: Glomerulus or Tubule?","volume":"34","author":"R Masereeuw","year":"2014","journal-title":"Seminars in Nephrology"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.tiv.2015.07.020","article-title":"Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology","volume":"29","author":"HAM Mutsaers","year":"2015","journal-title":"Toxicology in Vitro"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2215\/CJN.09981110","article-title":"Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins","volume":"6","author":"S Eloot","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1525-139X.2011.01003.x","article-title":"an Obituary for GFR as the main marker for kidney function?","volume":"25","author":"R Vanholder","year":"2012","journal-title":"Semin Dial"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa1000552","article-title":"A randomized, controlled trial of early versus late initiation of dialysis","volume":"363","author":"BA Cooper","year":"2010","journal-title":"N Engl J Med"},{"key":"ref32","article-title":"Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study","author":"MA Niewczas","year":"2014","journal-title":"Kidney Int"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"IW Wu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11306-011-0291-6","article-title":"Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)","volume":"8","author":"FM van der Kloet","year":"2012","journal-title":"Metabolomics"},{"key":"ref35","article-title":"Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD","author":"R Poesen","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref36","article-title":"Modern Epidemiology","author":"KJ Rothman","year":"2008"},{"issue":"2\u20133","key":"ref37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","article-title":"The SLC22 family with transporters of organic cations, anions and zwitterions","volume":"34","author":"H Koepsell","year":"2013","journal-title":"Mol Aspects Med"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbrc.2011.11.144","article-title":"Upregulation of BAD, a pro-apoptotic protein of the BCL2 family, in vascular smooth muscle cells exposed to uremic conditions","volume":"417","author":"E Tr\u00e9cherel","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1046\/j.1523-1755.2001.59780048.x","article-title":"Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils","volume":"78","author":"G Cohen","year":"2001","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"e32533","DOI":"10.1371\/journal.pone.0032533","article-title":"Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study","volume":"7","author":"P Ruggenenti","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"A Ramezani","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1681\/ASN.2015030279","article-title":"The Influence of CKD on Colonic Microbial Metabolism","volume":"27","author":"R Poesen","year":"2016","journal-title":"J Am Soc Nephrol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0168117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T02:18:29Z","timestamp":1658369909000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0168117"}},"subtitle":[],"editor":[{"given":"Petter","family":"Bjornstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,29]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0168117","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,29]]}}}